Laboratory Tests for Nocturia Evaluation
The essential laboratory test for evaluating nocturia is urinalysis, with additional tests including renal function (serum creatinine, BUN, electrolytes, eGFR), serum sodium, and glucose assessment depending on clinical context 1, 2, 3.
Core Laboratory Workup
Mandatory Testing
Urinalysis: This is the minimum requirement to rule out urinary tract infection, hematuria, proteinuria, and glycosuria 1, 2. All patients presenting with nocturia should have this performed.
Urine culture: Consider this when urinalysis is unreliable or if infection is suspected despite negative urinalysis 2.
Context-Dependent Testing
Renal function panel (serum creatinine, BUN, electrolytes, eGFR) should be checked in:
- Men with LUTS and poor flow, especially with hypertension or diabetes 1
- Patients at risk for chronic kidney disease 3
- Anyone being considered for desmopressin therapy (baseline serum sodium must be ≥135 mmol/L) 4
Serum sodium: Essential before initiating desmopressin and requires monitoring during treatment to prevent hyponatremia 4, 5, 6.
PSA (Prostate-Specific Antigen): In men, this helps predict prostate volume, growth risk, and bladder outlet obstruction 1.
Critical Non-Laboratory Assessments
While not laboratory tests, these are equally essential:
Frequency-volume chart/bladder diary (3 days): This is the key diagnostic tool to differentiate nocturnal polyuria from reduced bladder capacity 1, 4, 7, 8. It provides objective data on voided volumes and timing.
Post-void residual (PVR): Measured by ultrasound, not a lab test but important for identifying retention risk 1, 2.
Common Pitfalls
The most frequent error is failing to obtain a bladder diary, which is essential for distinguishing nocturnal polyuria (large volume voids) from overactive bladder (small volume voids) 2. This distinction fundamentally changes treatment approach.
Do not skip serum sodium testing if considering desmopressin - hyponatremia is a serious adverse effect requiring baseline and ongoing monitoring 4, 5.